Produced by Araxis Merge on 2/19/2018 2:07:54 PM Eastern Standard Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
| # | Location | File | Last Modified |
|---|---|---|---|
| 1 | OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package.zip\OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package\OneVA_Pharmacy_CAS_MPDU_Build-2_Test_Cases | CAS_MPDU_TC_033_ Modify PSD DEA SUBOXONE Report to correct patient count logic..docx | Mon Jan 8 17:08:40 2018 UTC |
| 2 | OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package.zip\OneVA_Pharmacy_CAS_MPDU_Build-2_CIF_Package\OneVA_Pharmacy_CAS_MPDU_Build-2_Test_Cases | CAS_MPDU_TC_033_ Modify PSD DEA SUBOXONE Report to correct patient count logic..docx | Mon Feb 19 18:03:13 2018 UTC |
| Description | Between Files 1 and 2 |
|
|---|---|---|
| Text Blocks | Lines | |
| Unchanged | 1 | 584 |
| Changed | 0 | 0 |
| Inserted | 0 | 0 |
| Removed | 0 | 0 |
| Whitespace | |
|---|---|
| Character case | Differences in character case are significant |
| Line endings | Differences in line endings (CR and LF characters) are ignored |
| CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
| 1 | Department of Vetera ns Affairs | |
| 2 | ||
| 3 | Clinical A ncillary S ervices (C AS) | |
| 4 | ||
| 5 | ||
| 6 | Build 2 | |
| 7 | Sprint-3 | |
| 8 | Test Case CAS_TC_033 | |
| 9 | ||
| 10 | CLIN# 0004 AE | |
| 11 | December 2 017 | |
| 12 | Version 1. 0 | |
| 13 | Revision H istory | |
| 14 | Date | |
| 15 | Version | |
| 16 | Descriptio n | |
| 17 | Author | |
| 18 | 08/04/2017 | |
| 19 | 1.0 | |
| 20 | Initial dr aft | |
| 21 | Joseph A. McGovern | |
| 22 | Template R evision Hi story | |
| 23 | Date | |
| 24 | Version | |
| 25 | Descriptio n | |
| 26 | Author | |
| 27 | 08/04/2017 | |
| 28 | 1.0 | |
| 29 | Constructe d for CAS based on h istorical Test Case format use d on prior VA Projec ts | |
| 30 | Joseph A. McGovern | |
| 31 | ||
| 32 | ||
| 33 | Table of C ontents | |
| 34 | 1Product D escription 1 | |
| 35 | 1.1Purpose 1 | |
| 36 | 1.2Scope1 | |
| 37 | 2Test Case | |
| 38 | Appendix A .Acronyms & Abbrevia tions9 | |
| 39 | ||
| 40 | ||
| 41 | Product De scription | |
| 42 | OneVA Phar macy Clin ical Ancil lary Servi ces (CAS) project | |
| 43 | Purpose | |
| 44 | The purpos e of this document i s to devel op test ca se scenari os to iden tify, clar ify, and o rganize CA S applicat ion requir ements. Th e test cas e is made up of a se t of possi ble sequen ces of int eractions between sy stems and users in t he CHYSHR and DAYTSH R environm ents to va lidate and verify th at OneVA P harmacy so ftware Out patient Ph armacy Pre scription Processing will allo w the exis ting PSD D EA SUBOXON E report m odified to correct t he logic t hat counts patients that were dispensed Suboxone s o that eac h patient is only co unted once per presc ribing pro vider to a ccount for patients who may ne ed multipl e strength s of Subox one to mak e up the c orrect dos age dispen sed. | |
| 45 | The CHYSHR environme nt is the Host site. The DAYT SHR enviro nment is t he dispens ing site ( remote). | |
| 46 | The test c ase should contain a ll system activities that have significa nce to the Pharmacis t users. | |
| 47 | Scope | |
| 48 | OneVA Phar macy softw are Outpat ient Pharm acy Prescr iption Pro cessing wi ll allow t he existin g PSD DEA SUBOXONE r eport modi fied to co rrect the logic that counts pa tients tha t were dis pensed Sub oxone so t hat each p atient is only count ed once pe r prescrib ing provid er to acco unt for pa tients who may need multiple s trengths o f Suboxone to make u p the corr ect dosage dispensed . | |
| 49 | Test Case | |
| 50 | CAS Test C ases and s upporting test scrip ts will be recorded managed in VA Enterp rise Jazz Rational Q uality Man ager Tool PBM(QM). Stakeholde rs can als o provide inputs abo ut the cur rent set o f test cas es as well as sugges t some mor e missing test cases . | |
| 51 | This test case will: | |
| 52 | Capture an d communic ate functi onal requi rements fo r software developme nt; and | |
| 53 | Provide a set of tes t inputs, execution conditions , and expe cted resul ts develop ed for a p articular objective, such as t o exercise a particu lar progra m path or to verify compliance with a sp ecific req uirement o r defect r emediation . | |
| 54 | The existi ng PSD DEA SUBOXONE report mod ified to c orrect the logic tha t counts p atients th at were di spensed Su boxone so that each patient is only coun ted once p er prescri bing provi der to acc ount for p atients wh o may need multiple strengths of Suboxon e to make up the cor rect dosag e dispense dWhen the prescripti on is bloc ked, prese nt the use r with the following error mes sage | |
| 55 | ||
| 56 | Field | |
| 57 | Descriptio n | |
| 58 | Test Case ID: | |
| 59 | CAS_MPDU_T C_033_ Mod ify PSD DE A SUBOXONE Report to correct p atient cou nt logic. | |
| 60 | RTC ID: | |
| 61 | 616993 | |
| 62 | RM ID: | |
| 63 | 949402 | |
| 64 | QM ID: | |
| 65 | 167730 | |
| 66 | Tester: | |
| 67 | Samatha Gi rla | |
| 68 | Environmen t: | |
| 69 | DAYTSHR | |
| 70 | Build : | |
| 71 | PSD_3_83_2 0171218A.K ID,PSO_7_5 05_2017121 9A.KID,PSS _1_219_201 71204B.KID ,XU_8_689_ 20171124B. KID | |
| 72 | ||
| 73 | Use Case N ame: | |
| 74 | Report/Aud iting | |
| 75 | Scenario: | |
| 76 | As a provi der, I nee d the exis ting PSD D EA SUBOXON E report m odified to correct t he logic t hat counts patients that were dispensed Suboxone s o that eac h patient is only co unted once per presc ribing pro vider to a ccount for patients who may ne ed multipl e strength s of Subox one to mak e up the c orrect dos age dispen sed. | |
| 77 | Actors: | |
| 78 | Pharmacist | |
| 79 | Pre-Condit ion: | |
| 80 | The Pharma cist must have an ac tive VistA account w ith access to the On eVA Pharma cy Program . | |
| 81 | ||
| 82 | ||
| 83 | ||
| 84 | Post-Condi tion | |
| 85 | Upon entry of valid access and verify co des on Out Patient Ph armacy Pre scription Processing system wi ll allow t he existin g PSD DEA SUBOXONE r eport modi fied to co rrect the logic that counts pa tients tha t were dis pensed Sub oxone so t hat each p atient is only count ed once pe r prescrib ing provid er to acco unt for pa tients who may need multiple s trengths o f Suboxone to make u p the corr ect dosage dispensed . | |
| 86 | ||
| 87 | Steps | |
| 88 | ||
| 89 | Pass | |
| 90 | Fail | |
| 91 | ||
| 92 | Actions | |
| 93 | Pass | |
| 94 | ||
| 95 | ||
| 96 | Log into y our local vista inst ance. | |
| 97 | ||
| 98 | ||
| 99 | ||
| 100 | Expected R esults | |
| 101 | ||
| 102 | ||
| 103 | ||
| 104 | User will be taken t o the acce ss/verify code promp ts. | |
| 105 | ||
| 106 | ||
| 107 | ||
| 108 | Actions | |
| 109 | Pass | |
| 110 | ||
| 111 | ||
| 112 | Enter your access/ve rify code( s). | |
| 113 | ||
| 114 | ||
| 115 | ||
| 116 | Expected R esults | |
| 117 | ||
| 118 | ||
| 119 | ||
| 120 | User it ta ken to the default m enu promp t. | |
| 121 | ||
| 122 | ||
| 123 | ||
| 124 | Actions | |
| 125 | Pass | |
| 126 | ||
| 127 | ||
| 128 | When promp ted ‘ISPA0 4:DAYTSHR> ’ D ^XUP | |
| 129 | :”, press <return> | |
| 130 | ||
| 131 | ||
| 132 | ||
| 133 | Expected R esults | |
| 134 | ||
| 135 | ||
| 136 | ||
| 137 | Select OPT ION NAME: | |
| 138 | ||
| 139 | ||
| 140 | ||
| 141 | Actions | |
| 142 | Pass | |
| 143 | ||
| 144 | ||
| 145 | Select Opt ion ‘PSD D EA SUBOXON E’ press < Return> | |
| 146 | ||
| 147 | ||
| 148 | ||
| 149 | Expected R esults | |
| 150 | ||
| 151 | ||
| 152 | ||
| 153 | You may s elect a si ngle or mu ltiple Div isions, | |
| 154 | or en ter ^ALL t o select a ll Divisio ns. | |
| 155 | ||
| 156 | Division: | |
| 157 | ||
| 158 | ||
| 159 | ||
| 160 | Actions | |
| 161 | Pass | |
| 162 | ||
| 163 | ||
| 164 | Division: ^ALL and p ress <Retu rn> | |
| 165 | ||
| 166 | ||
| 167 | ||
| 168 | Expected R esults | |
| 169 | ||
| 170 | ||
| 171 | ||
| 172 | Start Date : | |
| 173 | ||
| 174 | ||
| 175 | ||
| 176 | Actions | |
| 177 | Pass | |
| 178 | ||
| 179 | ||
| 180 | Start Date :T-60 and press <Ret urn> | |
| 181 | ||
| 182 | ||
| 183 | ||
| 184 | Expected R esults | |
| 185 | ||
| 186 | ||
| 187 | ||
| 188 | END Date: | |
| 189 | ||
| 190 | ||
| 191 | 7. | |
| 192 | Actions | |
| 193 | Pass | |
| 194 | ||
| 195 | ||
| 196 | END Date: T and pres s <Return> | |
| 197 | ||
| 198 | ||
| 199 | ||
| 200 | Expected R esults | |
| 201 | ||
| 202 | ||
| 203 | ||
| 204 | You may se lect a sin gle provid er, severa l provider s, | |
| 205 | or en ter ^ALL t o select a ll provide rs. | |
| 206 | ||
| 207 | ||
| 208 | Select Pro vider: | |
| 209 | ||
| 210 | ||
| 211 | ||
| 212 | 8. | |
| 213 | Actions | |
| 214 | Pass | |
| 215 | ||
| 216 | ||
| 217 | Select Pro vider: ^AL L and pres s <Return> | |
| 218 | ||
| 219 | ||
| 220 | ||
| 221 | Expected R esults | |
| 222 | ||
| 223 | ||
| 224 | ||
| 225 | Detailed/S ummary Rep ort: D// | |
| 226 | ||
| 227 | ||
| 228 | 9. | |
| 229 | Actions | |
| 230 | Pass | |
| 231 | ||
| 232 | ||
| 233 | Detailed/S ummary Rep ort: D//Su mmary and press <Ret urn> until you see t he DEA DAT A-Waived P ractitione r Report | |
| 234 | ||
| 235 | ||
| 236 | ||
| 237 | Expected R esults | |
| 238 | ||
| 239 | ||
| 240 | ||
| 241 | DEA DATA-W aived Prac titioner R eport Jan 0 3, 2018 | |
| 242 | Summary Report | |
| 243 | DIVISION : DAYTON | |
| 244 | Nov 04, 2017 t o Jan 03, 2018 Page: 1 | |
| 245 | ||
| 246 | PROVIDER/D RUG # OF PATIENTS | |
| 247 | ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- | |
| 248 | FISHER,BRA DLEY W 1 | |
| 249 | BUPRENO RPHINE 8MG /NALOXONE 2MG SL TAB | |
| 250 | ||
| 251 | ||
| 252 | ||
| 253 | DEA DATA -Waived Pr actitioner Report Jan 03, 2018 | |
| 254 | Summary Report | |
| 255 | DI VISION: On eVA Pharma cy | |
| 256 | Nov 04, 2017 t o Jan 03, 2018 Page: 2 | |
| 257 | ||
| 258 | PROVIDER/D RUG # OF PATIENTS | |
| 259 | ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- | |
| 260 | FISHER,BRA DLEY W 3 | |
| 261 | ABUPREN | |
| 262 | SUBOXON E BUPRENOR PHINE | |
| 263 | ||
| 264 | BUTLER,BRA NDON L 1 | |
| 265 | ABUPREN | |
| 266 | ||
| 267 | GIRLA,SAMA THA 1 | |
| 268 | BUPRENO RPHINE 2MG /NALOXONE 0.5MG SL T AB | |
| 269 | BUPRENO RPHINE 8MG /NALOXONE 2MG SL TAB | |
| 270 | ||
| 271 | ANWER,MOHA MED H 1 | |
| 272 | BUPRENO RPHINE 8MG /NALOXONE 2MG SL TAB | |
| 273 | ||
| 274 | ISPA04:DAY TSHR> | |
| 275 | ||
| 276 | ||
| 277 | ||
| 278 | Acronyms & Abbreviat ions | |
| 279 | Acronym | |
| 280 | Definition | |
| 281 | CAS | |
| 282 | Clinical A ncillary S ervices | |
| 283 | CHYSHR | |
| 284 | Test Envir onment fo r Host sit e | |
| 285 | CPRS | |
| 286 | Computeriz ed Patient Record Sy stem | |
| 287 | DAYTSHR | |
| 288 | Test Envir onment fo r the disp ensing sit e (remote) | |
| 289 | VHA | |
| 290 | Veteran’s Health Adm inistratio n | |
| 291 | VistA | |
| 292 | Veterans H ealth Info rmation Sy stems and Technology Architect ure |
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.